| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.RES.74.6.1141 |
| P698 | PubMed publication ID | 8187280 |
| P50 | author | Kathy K. Griendling | Q52725890 |
| P2093 | author name string | R W Alexander | |
| C A Minieri | |||
| J D Ollerenshaw | |||
| P433 | issue | 6 | |
| P304 | page(s) | 1141-1148 | |
| P577 | publication date | 1994-06-01 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells | |
| P478 | volume | 74 |
| Q42071792 | 5-Hydroxytryptamine1A receptor/Gibetagamma stimulates mitogen-activated protein kinase via NAD(P)H oxidase and reactive oxygen species upstream of src in chinese hamster ovary fibroblasts |
| Q44546829 | 5-Lipoxygenase is involved in the angiotensin II-induced NAD(P)H-oxidase activation |
| Q46256199 | A Mini-Review of the NADPH oxidases in Vascular Dementia: Correlation with NOXs and Risk Factors for VaD. |
| Q92408957 | A Review of the Actions of Endogenous and Exogenous Vasoactive Substances during the Estrous Cycle and Pregnancy in Rats |
| Q64103472 | A catalytic career: Studies spanning glutamine synthetase, phospholipase C, peroxiredoxin, and the intracellular messenger role of hydrogen peroxide |
| Q36893277 | A comparison of reactive oxygen species metabolism in the rat aorta and vena cava: focus on xanthine oxidase |
| Q33625889 | A current view of brain renin-angiotensin system: Is the (pro)renin receptor the missing link? |
| Q35099138 | A local pancreatic renin-angiotensin system: endocrine and exocrine roles |
| Q35042069 | A metabolic biofuel cell: conversion of human leukocyte metabolic activity to electrical currents |
| Q39565276 | A microdialysis method to measure in vivo hydrogen peroxide and superoxide in various rodent tissues. |
| Q39205915 | A model of interaction between nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and apocynin analogues by docking method |
| Q44100425 | A new inorganic vasodilator, trans-[Ru(NO)(NH(3))(4)(POEt)(3)](PF(6))(3): hypotensive effect of endothelium-dependent and -independent vasodilators in different hypertensive animals models |
| Q57364207 | A novel pathway of cellular phosphatidylinositol(3,4,5)-trisphosphate synthesis is regulated by oxidative stress |
| Q35565491 | A novel pleiotropic effect of statins: prevention of cardiac hypertrophy by cholesterol-independent mechanisms |
| Q37717867 | A role for innate immunity in the development of hypertension |
| Q37272651 | A role for mitochondrial oxidants in stress-induced premature senescence of human vascular smooth muscle cells |
| Q37814934 | ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease |
| Q35603932 | ADMA and oxidative stress |
| Q37954821 | AMP-activated protein kinase and the control of smooth muscle cell hyperproliferation in vascular disease. |
| Q42921057 | AT1 receptor and NAD(P)H oxidase mediate angiotensin II-stimulated antioxidant enzymes and mitogen-activated protein kinase activity in the rat hypothalamus |
| Q37274124 | AT2 receptors: functional relevance in cardiovascular disease. |
| Q54102504 | Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: a potential role of bradykinin. |
| Q37591224 | Acetylation of cyclophilin A is required for its secretion and vascular cell activation |
| Q28077812 | Action mechanism and cardiovascular effect of anthocyanins: a systematic review of animal and human studies |
| Q37471445 | Activated intrarenal reactive oxygen species and renin angiotensin system in IgA nephropathy |
| Q44374168 | Activation of NAD(P)H oxidase by lipid hydroperoxides: mechanism of oxidant-mediated smooth muscle cytotoxicity. |
| Q58464795 | Activation of cardiac renin-angiotensin system in unstable angina |
| Q34158064 | Activation of the ACE2/Ang-(1-7)/Mas pathway reduces oxygen-glucose deprivation-induced tissue swelling, ROS production, and cell death in mouse brain with angiotensin II overproduction |
| Q44635305 | Acute angiotensin II increases plasma F2-isoprostanes in salt-replete human hypertensives |
| Q43852493 | Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression |
| Q33936984 | Adipose tissue-specific dysregulation of angiotensinogen by oxidative stress in obesity |
| Q35670659 | Adrenomedullin in vascular diseases |
| Q38395507 | Advances in the pathogenesis of cardiorenal syndrome type 3. |
| Q28390943 | Air pollution exposure potentiates hypertension through reactive oxygen species-mediated activation of Rho/ROCK |
| Q53592958 | Aliskiren and l-arginine treatments restore depressed baroreflex sensitivity and decrease oxidative stress in renovascular hypertension rats. |
| Q42181849 | Allopurinol alleviates hypertension and proteinuria in high fructose, high salt and high fat induced model of metabolic syndrome. |
| Q43105419 | Altered function of nitrergic nerves inhibiting sympathetic neurotransmission in mesenteric vascular beds of renovascular hypertensive rats. |
| Q35028046 | Alternative pathways of angiotensin II production in the human saphenous vein |
| Q37561135 | Amlodipine increased endothelial nitric oxide and decreased nitroxidative stress disproportionately to blood pressure changes |
| Q40800584 | Analysis of reactive oxygen species in cell death |
| Q92554009 | Anatomically specific reactive oxygen species production participates in Marfan syndrome aneurysm formation |
| Q37486954 | Andrographolide, a Novel NF- κ B Inhibitor, Induces Vascular Smooth Muscle Cell Apoptosis via a Ceramide-p47phox-ROS Signaling Cascade. |
| Q38937856 | Angiotensin II Causes Apoptosis of Adult Hippocampal Neural Stem Cells and Memory Impairment Through the Action on AMPK-PGC1α Signaling in Heart Failure |
| Q46265113 | Angiotensin II Causes Neuronal Damage in Stretch-Injured Neurons: Protective Effects of Losartan, an Angiotensin T1 Receptor Blocker. |
| Q40783940 | Angiotensin II Destabilizes Coronary Plaques in Watanabe Heritable Hyperlipidemic Rabbits |
| Q89006965 | Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology |
| Q44318888 | Angiotensin II activates NADPH oxidase in isolated rat hearts subjected to ischaemia-reperfusion. |
| Q34239830 | Angiotensin II and atherosclerosis |
| Q36649671 | Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade |
| Q34963306 | Angiotensin II and nitric oxide interaction. |
| Q37859447 | Angiotensin II and the vascular phenotype in hypertension |
| Q34610027 | Angiotensin II as a cardiovascular risk factor |
| Q35028013 | Angiotensin II induced catabolic effect and muscle atrophy are redox dependent |
| Q30433144 | Angiotensin II induces a region-specific hyperplasia of the ascending aorta through regulation of inhibitor of differentiation 3. |
| Q34099697 | Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-kappaB (NF-kappaB) transcription factor |
| Q83307079 | Angiotensin II induces human astrocyte senescence through reactive oxygen species production |
| Q24336297 | Angiotensin II inhibits the Na+-K+ pump via PKC-dependent activation of NADPH oxidase |
| Q34076068 | Angiotensin II mediated signal transduction. Important role of tyrosine kinases. |
| Q36039299 | Angiotensin II revisited: new roles in inflammation, immunology and aging |
| Q36312399 | Angiotensin II stimulates superoxide production in the thick ascending limb by activating NOX4. |
| Q30428077 | Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension |
| Q26998758 | Angiotensin II, NADPH oxidase, and redox signaling in the vasculature |
| Q55365740 | Angiotensin II, Oxidative Stress, and Sympathetic Nervous System Hyperactivity in Heart Failure. |
| Q40365120 | Angiotensin II, atherosclerosis, and aortic aneurysms |
| Q37701122 | Angiotensin II, from vasoconstrictor to growth factor: a paradigm shift |
| Q37905538 | Angiotensin II-derived reactive oxygen species underpinning the processing of the cardiovascular reflexes in the medulla oblongata. |
| Q44372219 | Angiotensin II-induced modulation of endothelium-dependent relaxation in rabbit mesenteric resistance arteries |
| Q34378188 | Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone |
| Q40275746 | Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways. |
| Q34555180 | Angiotensin II-mediated signal transduction pathways. |
| Q34251889 | Angiotensin II-related hypertension and eye diseases |
| Q35818228 | Angiotensin converting enzyme inhibition increases ADMA concentration in patients on maintenance hemodialysis--a randomized cross-over study |
| Q44147870 | Angiotensin receptor antagonist losartan improves endothelial function of epicardial coronary arteries in patients with essential hypertension. |
| Q36439575 | Angiotensin receptor blockade recovers hepatic UCP2 expression and aconitase and SDH activities and ameliorates hepatic oxidative damage in insulin resistant rats |
| Q35003882 | Angiotensin receptors as determinants of life span |
| Q47830704 | Angiotensin, LDL peroxidation and atherosclerosis. |
| Q35001863 | Angiotensin-II induced hypertension and renovascular remodelling in tissue inhibitor of metalloproteinase 2 knockout mice |
| Q38110281 | Angiotensin-II-derived reactive oxygen species on baroreflex sensitivity during hypertension: new perspectives. |
| Q46466725 | Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats |
| Q34115516 | Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells |
| Q44411145 | Angiotensin-converting enzyme inhibition but not angiotensin II type 1 receptor antagonism augments coronary release of tissue plasminogen activator in hypertensive patients |
| Q35663915 | Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease. |
| Q36087047 | Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2 |
| Q34028407 | Antihypertensive drugs and reversing of endothelial dysfunction in hypertension. |
| Q36210461 | Antihypertensive effect of gomisin A from Schisandra chinensis on angiotensin II-induced hypertension via preservation of nitric oxide bioavailability |
| Q38390933 | Antihypertensive effects of astaxanthin. |
| Q64111047 | Antioxidant Defense, Oxidative Modification, and Salivary Gland Function in an Early Phase of Cerulein Pancreatitis |
| Q44629556 | Antioxidant enzyme gene expression in congestive heart failure following myocardial infarction |
| Q31864155 | Antioxidant treatment induces transcription and expression of transforming growth factor beta in cultured renal proximal tubular cells |
| Q43271695 | Antioxidant treatment with tempol and apocynin prevents endothelial dysfunction and development of renovascular hypertension. |
| Q60723141 | Antioxidant-oxidant balance in the glomerulus and proximal tubule of the rat kidney |
| Q71001066 | Antioxidants differentially affect nuclear factor kappa B-mediated nitric oxide synthase expression in vascular smooth muscle cells |
| Q44205480 | Antioxidants inhibit endothelin-1 (1-31)-induced proliferation of vascular smooth muscle cells via the inhibition of mitogen-activated protein (MAP) kinase and activator protein-1 (AP-1). |
| Q92483463 | Aortic remodelling induced by obstructive apneas is normalized with mesenchymal stem cells infusion |
| Q46314700 | Apocynin attenuates tubular apoptosis and tubulointerstitial fibrosis in transgenic mice independent of hypertension |
| Q41679559 | Apocynin reduced doxycycline-induced acute liver injury in ovariectomized mice |
| Q36481340 | Aquaporin 1, Nox1, and Ask1 mediate oxidant-induced smooth muscle cell hypertrophy |
| Q36105342 | Arachidonic acid activates c-jun N-terminal kinase through NADPH oxidase in rabbit proximal tubular epithelial cells |
| Q74242052 | Arachidonic acid pretreatment enhances smooth muscle cell migration via increased Ca2+ influx |
| Q36348897 | Arterial Smooth Muscle Mitochondria Amplify Hydrogen Peroxide Microdomains Functionally Coupled to L-Type Calcium Channels. |
| Q53743595 | Ascending versus descending balloon counterpulsation. |
| Q48787719 | Association between N-terminal pro-brain natriuretic peptide levels and contrast-induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome. |
| Q41056189 | Association between NAD(P)H oxidase p22phox gene variants and acute myocardial infarction in a Han Chinese population |
| Q36758244 | Association of -77T>C and Arg194trp polymorphisms of XRCC1 with risk of coronary artery diseases in Iranian population |
| Q35204621 | Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study. |
| Q44631778 | Association of the p22phox Component of NAD(P)H Oxidase With Susceptibility to Diabetic Nephropathy in Patients With Type 1 Diabetes |
| Q91577823 | Attenuation of Angiotensin II-Induced Hypertension in BubR1 Low-Expression Mice Via Repression of Angiotensin II Receptor 1 Overexpression |
| Q37363718 | Attenuation of angiotensin II-induced vascular dysfunction and hypertension by overexpression of Thioredoxin 2. |
| Q36449123 | Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease |
| Q64231101 | BCL6 Attenuates Proliferation and Oxidative Stress of Vascular Smooth Muscle Cells in Hypertension |
| Q26998655 | Bang-bang model for regulation of local blood flow |
| Q36832286 | Baseline clinical and angiographic data in the Quinapril Ischemic Event (QUIET) Trial |
| Q41984858 | Beneficial effects of caffeic acid phenethyl ester in a rat model of vascular injury |
| Q55486963 | Benzbromarone Attenuates Oxidative Stress in Angiotensin II- and Salt-Induced Hypertensive Model Rats. |
| Q42945864 | Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase |
| Q64897924 | Bilirubin, a new therapeutic for kidney transplant? |
| Q35755497 | Bilirubin, renal hemodynamics, and blood pressure |
| Q37247700 | Binding of EBP50 to Nox organizing subunit p47phox is pivotal to cellular reactive species generation and altered vascular phenotype |
| Q35042904 | Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells |
| Q24563415 | Blasts from the past |
| Q80295422 | Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation |
| Q33783946 | Blockade of endogenous tissue kallikrein aggravates renal injury by enhancing oxidative stress and inhibiting matrix degradation |
| Q49232671 | Blocking LPA-dependent signaling increases ovarian cancer cell death in response to chemotherapy. |
| Q35705401 | Boldine Ameliorates Vascular Oxidative Stress and Endothelial Dysfunction: Therapeutic Implication for Hypertension and Diabetes |
| Q36216393 | Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities |
| Q37049094 | Brain angiotensin receptors and binding proteins |
| Q74341161 | C242T polymorphism of the p22 phox gene is not associated with peripheral arterial occlusive disease |
| Q80975563 | CV-11974, angiotensin II type I receptor antagonist, reduces the severity of indomethacin-induced rat enteritis |
| Q33989856 | Calcium signaling and oxidant stress in the vasculature |
| Q33655919 | Calmodulin kinase II is required for angiotensin II-mediated vascular smooth muscle hypertrophy. |
| Q36204071 | Candesartan Mediated Amelioration of Cisplatin-Induced Testicular Damage Is Associated with Alterations in Expression Patterns of Nephrin and Podocin |
| Q44657547 | Candesartan Reduces Oxidative Stress and Inflammation in Patients with Essential Hypertension |
| Q42792478 | Candesartan and amlodipine combination therapy provides powerful vascular protection in stroke-prone spontaneously hypertensive rats |
| Q44855219 | Candesartan cilexetil protects cavernous tissue in spontaneously hypertensive rats |
| Q89976543 | Cannabidiol Effects on Phospholipid Metabolism in Keratinocytes from Patients with Psoriasis Vulgaris |
| Q99629126 | Cannabidiol protects keratinocyte cell membranes following exposure to UVB and hydrogen peroxide |
| Q53614139 | Captopril prevents myosin light chain phosphatase isoform switching to preserve normal cGMP-mediated vasodilatation. |
| Q42145276 | Cardiac myocyte-specific transgenic ecSOD targets mitochondria to protect against Ca(2+) induced permeability transition |
| Q36561841 | Cardinal role of the intrarenal renin-angiotensin system in the pathogenesis of diabetic nephropathy |
| Q34571610 | Cardiorenal syndrome caused by heart failure with preserved ejection fraction |
| Q37145749 | Cardiorenal syndrome: A literature review |
| Q38068097 | Cardiorenal syndrome: pathophysiology and potential targets for clinical management |
| Q37696360 | Cardiorenal syndrome: still not a defined entity |
| Q36855006 | Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from the ONTARGET Trial Programme |
| Q35973528 | Carotid body function in heart failure |
| Q37295650 | Caveolin and MAP kinase interaction in angiotensin II preconditioning of the myocardium |
| Q33661117 | Cell signaling by protein carbonylation and decarbonylation |
| Q34006311 | Cell signaling by reactive nitrogen and oxygen species in atherosclerosis |
| Q42052694 | Cell signaling promoting protein carbonylation does not cause sulfhydryl oxidation: Implications to the mechanism of redox signaling |
| Q22010372 | Cell transformation by the superoxide-generating oxidase Mox1 |
| Q91577811 | Cellular Mechanisms of Aortic Aneurysm Formation |
| Q46252086 | Cellular and Oxidative Mechanisms Associated with Interleukin-6 Signaling in the Vasculature |
| Q39792932 | Cellular and molecular mechanisms of endothelial cell dysfunction |
| Q64079080 | Central Inhibition of Tumor Necrosis Factor Alpha Reduces Hypertension by Attenuating Oxidative Stress in the Rostral Ventrolateral Medulla in Renovascular Hypertensive Rats |
| Q34761161 | Central role of the AT(1)-receptor in atherosclerosis |
| Q35733922 | Centrally mediated erectile dysfunction in rats with type 1 diabetes: role of angiotensin II and superoxide |
| Q35545556 | Cerebrovascular effects of amyloid-beta peptides: mechanisms and implications for Alzheimer's dementia |
| Q41952038 | Characteristic changes in coronary artery at the early hyperglycaemic stage in a rat type 2 diabetes model and the effects of pravastatin |
| Q40913837 | Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin |
| Q46359673 | Chronic administration of sodium nitrite prevents hypertension and protects arterial endothelial function by reducing oxidative stress in angiotensin II-infused mice |
| Q43148859 | Chronic antioxidant treatment improves arterial renovascular hypertension and oxidative stress markers in the kidney in Wistar rats. |
| Q43179284 | Chronic ethanol ingestion increases superoxide production and NADPH oxidase expression in the lung |
| Q51343625 | Chymase-dependent production of angiotensin II: an old enzyme in old hearts. |
| Q28345538 | Cigarette smoking in men and vascular responsiveness |
| Q37293293 | Clinical achievements of impedance analysis |
| Q35992729 | Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets |
| Q34886548 | Combined aliskiren and L-arginine treatment has antihypertensive effects and prevents vascular endothelial dysfunction in a model of renovascular hypertension |
| Q38072272 | Coming full circle in diabetes mellitus: from complications to initiation. |
| Q77371797 | Comparison of effects of ascorbic acid on endothelium-dependent vasodilation in patients with chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy versus patients with effort angina pectoris secondary to coronary artery di |
| Q78115660 | Comparison of glyceryl trinitrate-induced with pentaerythrityl tetranitrate-induced in vivo formation of superoxide radicals: effect of vitamin C |
| Q38712571 | Comparison of protective effect of ascorbic acid on redox and endocannabinoid systems interactions in in vitro cultured human skin fibroblasts exposed to UV radiation and hydrogen peroxide |
| Q33360225 | Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidase pathway |
| Q33417350 | Contaminated heparin and outcomes after cardiac surgery: a retrospective propensity-matched cohort study |
| Q41137411 | Contribution of oxidative stress to pulmonary arterial hypertension |
| Q74254223 | Contribution of the renin-angiotensin system to subsensitivity of soluble guanylyl cyclase in TGR(mREN2)27 rats |
| Q33280387 | Control of PDGF-induced reactive oxygen species (ROS) generation and signal transduction in human lens epithelial cells |
| Q40403384 | Control of coronary blood flow by autacoids |
| Q33959651 | Coronary microcirculation: physiology and pharmacology |
| Q35210184 | Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease |
| Q34304673 | Crosstalk between endothelin and nitric oxide in the control of vascular tone. |
| Q38667506 | Crosstalk of mitochondria with NADPH oxidase via reactive oxygen and nitrogen species signalling and its role for vascular function. |
| Q36168835 | Crucial role of Rho-nuclear factor-kappaB axis in angiotensin II-induced renal injury |
| Q38132120 | Current status of NADPH oxidase research in cardiovascular pharmacology |
| Q42492868 | Cyclo-oxygenase-2 knockout genotype in mice is associated with blunted angiotensin II-induced oxidative stress and hypertension |
| Q37280611 | Cyclophilin A is required for angiotensin II-induced p47phox translocation to caveolae in vascular smooth muscle cells. |
| Q42043334 | Cyclophilin A promotes cardiac hypertrophy in apolipoprotein E-deficient mice |
| Q37801787 | Cyclophilin A: promising new target in cardiovascular therapy |
| Q34157216 | Cytochrome P450 1B1 contributes to angiotensin II-induced hypertension and associated pathophysiology |
| Q36651392 | DNA damage and augmented oxidative stress in bone marrow mononuclear cells from Angiotensin-dependent hypertensive mice. |
| Q42543951 | Decoupled syndecan 1 mRNA and protein expression is differentially regulated by angiotensin II in macrophages |
| Q37512463 | Decreased neointimal formation in Nox2-deficient mice reveals a direct role for NADPH oxidase in the response to arterial injury. |
| Q21129242 | Deficiency of Nox2 prevents angiotensin II-induced inward remodeling in cerebral arterioles |
| Q55333348 | Deletion of NAD(P)H Oxidase 2 Prevents Angiotensin II-Induced Skeletal Muscle Atrophy. |
| Q73045631 | Detection of superoxide anion released extracellularly by endothelial cells using cytochrome c reduction, ESR, fluorescence and lucigenin-enhanced chemiluminescence techniques |
| Q37633937 | Determinants of kidney oxygen consumption and their relationship to tissue oxygen tension in diabetes and hypertension. |
| Q79761188 | Determinants of platelet responsiveness to nitric oxide in patients with chronic heart failure |
| Q37029541 | Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISA |
| Q35857205 | Diabetes and hypertension: is there a common metabolic pathway? |
| Q37597721 | Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury |
| Q36312579 | Differences in oxidative stress status and expression of MKP-1 in dorsal medulla of transgenic rats with altered brain renin-angiotensin system |
| Q80080244 | Different pathomechanisms of essential and obesity-associated hypertension in adolescents |
| Q36276106 | Differential effects of AT1 receptor and Ca2+ channel blockade on atherosclerosis, inflammatory gene expression, and production of reactive oxygen species |
| Q37414119 | Differential effects of mechanical and biological stimuli on matrix metalloproteinase promoter activation in the thoracic aorta |
| Q35854556 | Differential modulation of bradykinin-induced relaxation of endothelin-1 and phenylephrine contractions of rat aorta by antioxidants. |
| Q42273452 | Differential role of angiotensin II receptor subtypes on endothelial superoxide formation |
| Q34092503 | Direct sensing of endothelial oxidants by vascular endothelial growth factor receptor-2 and c-Src |
| Q39639908 | Direct vascular actions of quercetin in aorta from renal hypertensive rats |
| Q41881015 | Discovery of new angiotensin converting enzyme (ACE) inhibitors from medicinal plants to treat hypertension using an in vitro assay. |
| Q42630995 | Dopaminergic degeneration is enhanced by chronic brain hypoperfusion and inhibited by angiotensin receptor blockage. |
| Q36292861 | Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes |
| Q89182413 | Drebrin regulates angiotensin II-induced aortic remodelling |
| Q38964342 | Drug Treatment of Hypertension: Focus on Vascular Health. |
| Q34981356 | Drugs targeting the renin-angiotensin-aldosterone system |
| Q37051475 | Dual effects of RAS blockade on blood pressure and podocyte function |
| Q38177120 | Dual roles of vascular-derived reactive oxygen species--with a special reference to hydrogen peroxide and cyclophilin A. |
| Q77718606 | Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesis |
| Q44124400 | Effect of ACE inhibitors on endothelial dysfunction: unanswered questions and implications for further investigation and therapy |
| Q42528774 | Effect of HDL and atherogenic lipoproteins on formation of O2- and renin release in juxtaglomerular cells |
| Q42470276 | Effect of angiotensin II on energetics, glucose metabolism and cytosolic NADH/NAD and NADPH/NADP redox in vascular smooth muscle |
| Q84135067 | Effect of angiotensin II on iron-transporting protein expression and subsequent intracellular labile iron concentration in human glomerular endothelial cells |
| Q36051529 | Effect of angiotensin receptor blockade on insulin sensitivity and endothelial function in abdominally obese hypertensive patients with impaired fasting glucose |
| Q48363169 | Effect of asiatic acid on the Ang II-AT1R-NADPH oxidase-NF-κB pathway in renovascular hypertensive rats. |
| Q44298308 | Effect of combination therapy with dipyridamole and quinapril in diabetic nephropathy |
| Q74530469 | Effect of enalapril on endothelial function in young insulin-dependent diabetic patients: a randomized, double-blind study |
| Q54102506 | Effect of intensive therapy for heart failure on the vasodilator response to exercise. |
| Q46505755 | Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome |
| Q42357988 | Effects of Benzo(e)pyrene on Reactive Oxygen/Nitrogen Species and Inflammatory Cytokines Induction in Human RPE Cells and Attenuation by Mitochondrial-involved Mechanism |
| Q33872775 | Effects of Hyperglycemia on Vascular Smooth Muscle Ca2+ Signaling |
| Q94026104 | Effects of Olmesartan and Azilsartan on Albuminuria and the Intrarenal Renin-Angiotensin System |
| Q57294005 | Effects of Pulmonary Hypertension and Right Ventricular Function in Short and Long-Term Kidney Function |
| Q44179119 | Effects of aging and AT-1 receptor blockade on NO synthase expression and renal function in SHR. |
| Q42452224 | Effects of angiotensin II on nitric oxide generation in growing and resting rat aortic endothelial cells |
| Q74255911 | Effects of angiotensin-converting enzyme inhibitor during warm blood cardioplegia |
| Q34510978 | Effects of antihypertensive drugs on endothelial dysfunction: clinical implications |
| Q43086895 | Effects of oxidative stress on endothelial modulation of contractions in aorta from renal hypertensive rats |
| Q73995256 | Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction. TREND Investigators. Trial on Reversing Endothelial Dysfunction |
| Q37300636 | Effects of taxifolin on the activity of angiotensin-converting enzyme and reactive oxygen and nitrogen species in the aorta of aging rats and rats treated with the nitric oxide synthase inhibitor and dexamethasone |
| Q37672751 | Effects of valsartan on inflammatory and oxidative stress markers in hypertensive, hyperglycemic patients: an open-label, prospective study |
| Q47254385 | Egg White Ovotransferrin-Derived ACE inhibitory Peptide Ameliorates Angiotensin II-Stimulated Insulin Resistance in Skeletal Muscle Cells. |
| Q58547678 | Eight-Week Consumption of High-Sucrose Diet Has a Pro-Oxidant Effect and Alters the Function of the Salivary Glands of Rats |
| Q43570075 | Electron spin resonance characterization of the NAD(P)H oxidase in vascular smooth muscle cells. |
| Q35083693 | Elevated endothelial nitric oxide bioactivity and resistance to angiotensin-dependent hypertension in 12/15-lipoxygenase knockout mice |
| Q92442235 | Emerging molecular mechanisms of vascular dementia |
| Q35161493 | Endothelial arginase II and atherosclerosis |
| Q35585925 | Endothelial control of vasomotion and nitric oxide production |
| Q35106721 | Endothelial dysfunction and inflammation: What is the link? |
| Q52773759 | Endothelial dysfunction in individuals born after fetal growth restriction: cardiovascular and renal consequences and preventive approaches. |
| Q34622231 | Endothelial dysfunction, angiotensin-converting enzyme inhibitors and calcium antagonists |
| Q41701279 | Endothelial dysfunction: a reversible clinical measure of atherogenic susceptibility and cardiovascular inefficiency |
| Q35188942 | Endothelial dysfunction: clinical strategies for treating oxidant stress |
| Q35013018 | Endothelial function. From vascular biology to clinical applications |
| Q37389059 | Endothelial nitric oxide synthase negatively regulates hydrogen peroxide-stimulated AMP-activated protein kinase in endothelial cells. |
| Q41252769 | Endothelium and platelet activity in heart failure |
| Q41068586 | Endothelium, for example. |
| Q30496168 | Endothelium-dependent coronary vasodilatation requires NADPH oxidase-derived reactive oxygen species |
| Q73356297 | Endothelium: a new target for cardiovascular therapeutics |
| Q35055893 | Enhanced expression and activity of Nox2 and Nox4 in the macula densa in ANG II-induced hypertensive mice |
| Q35152116 | Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit |
| Q44363823 | Enhanced vascular production of superoxide in OLETF rat after the onset of hyperglycemia |
| Q26776029 | Enzymatic antioxidant system in vascular inflammation and coronary artery disease |
| Q43576435 | Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. |
| Q38082442 | Estrogen and estrogen receptors in cardiovascular oxidative stress |
| Q34194262 | Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance |
| Q37285389 | Evidence of endothelial dysfunction in the development of Alzheimer's disease: Is Alzheimer's a vascular disorder? |
| Q43754697 | Evidence supporting abnormalities in nitric oxide synthase function induced by nitroglycerin in humans |
| Q36632902 | Exercise Training Attenuates Upregulation of p47(phox) and p67(phox) in Hearts of Diabetic Rats |
| Q35634433 | Exogenously-added copper/zinc superoxide dismutase rescues damage of endothelial cells from lethal irradiation |
| Q33601928 | Expression and distribution of NADPH oxidase isoforms in human myometrium--role in angiotensin II-induced hypertrophy. |
| Q47821756 | Extracellular and intracellular arachidonic acid-induced contractions in rat aorta. |
| Q36817413 | Farnesyl pyrophosphate synthase inhibitor, ibandronate, improves endothelial function in spontaneously hypertensive rats |
| Q36004556 | Fibroblast Angiotensin II Type 1a Receptors Contribute to Angiotensin II-Induced Medial Hyperplasia in the Ascending Aorta |
| Q34237411 | Formulating clinical strategies for angiotensin antagonism: a review of preclinical and clinical studies |
| Q34028489 | Free radical production and angiotensin |
| Q34099679 | Functional cross-talk between the cyclic AMP and Jak/STAT signaling pathways in vascular smooth muscle cells |
| Q44037745 | Functional evaluation of nonphagocytic NAD(P)H oxidases |
| Q26864672 | Functional sympatholysis in hypertension |
| Q40874945 | Future horizons in cardiovascular molecular therapeutics |
| Q90050408 | G Protein-Coupled Estrogen Receptor Protects From Angiotensin II-Induced Increases in Pulse Pressure and Oxidative Stress |
| Q57823442 | G-Protein-Coupled Receptors in Heart Disease |
| Q28206489 | GIT1 Mediates Src-dependent Activation of Phospholipase Cγ by Angiotensin II and Epidermal Growth Factor |
| Q46336412 | GPER Mediates Functional Endothelial Aging in Renal Arteries |
| Q50974094 | Gender differences in the generation of superoxide anions in the rat aorta. |
| Q36813240 | Genetic polymorphisms and endothelial dysfunction in patients with essential hypertension: a cross-sectional case-control study |
| Q47788358 | Glyc-oxidized LDL impair endothelial function more potently than oxidized LDL: role of enhanced oxidative stress. |
| Q42735963 | Glycated albumin activates NADPH oxidase in rat mesangial cells through up-regulation of p47phox |
| Q97551221 | Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities |
| Q42511668 | Guanylyl cyclase sensitivity to nitric oxide is protected by a thiol oxidation-driven interaction with thioredoxin-1. |
| Q36457347 | HERPUD1 protects against oxidative stress-induced apoptosis through downregulation of the inositol 1,4,5-trisphosphate receptor |
| Q37174133 | HIV-induced kidney cell injury: role of ROS-induced downregulated vitamin D receptor. |
| Q34028392 | HOPE gives reason for hope. Heart Outcomes Prevention Evaluation |
| Q38826590 | Heart failure and kidney dysfunction: epidemiology, mechanisms and management |
| Q44413028 | Heme Oxygenase-1 Gene Expression Attenuates Angiotensin II-Mediated DNA Damage in Endothelial Cells |
| Q79236385 | Heme oxygenase attenuated angiotensin II-mediated increase in cyclooxygenase activity and decreased isoprostane F2α in endothelial cells |
| Q36956772 | Heme oxygenase attenuates angiotensin II-mediated superoxide production in cultured mouse thick ascending loop of Henle cells |
| Q33767922 | Heme oxygenase-1 induction does not improve vascular relaxation in angiotensin II hypertensive mice |
| Q44253237 | Hemodynamic effects of metalloporphyrin catalytic antioxidants: structure-activity relationships and species specificity |
| Q38123517 | Hemodynamic regulation of reactive oxygen species: implications for vascular diseases |
| Q63805064 | High Protein Diet Induces Oxidative Stress in Rat Cerebral Cortex and Hypothalamus |
| Q92052018 | High-Fat Diet Affects Ceramide Content, Disturbs Mitochondrial Redox Balance, and Induces Apoptosis in the Submandibular Glands of Mice |
| Q39767111 | Homocysteine-induced oxidative stress upregulates chymase in mouse mastocytoma cells |
| Q77725793 | Hydralazine prevents endothelial dysfunction, but not the increase in superoxide production in nitric oxide-deficient hypertension |
| Q37359995 | Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug |
| Q36314716 | Hyperoxaluria-induced oxidative stress and antioxidants for renal protection |
| Q35210556 | Hypertension and other morbidities with Cushing's syndrome associated with corticosteroids: a review |
| Q37827620 | Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management |
| Q34028155 | Hypertensive vascular disease and inflammation: mechanical and humoral mechanisms |
| Q36326008 | Hypoxia-inducible factor-1alpha stabilization in nonhypoxic conditions: role of oxidation and intracellular ascorbate depletion |
| Q35021833 | Identification of Hic-5 as a novel scaffold for the MKK4/p54 JNK pathway in the development of abdominal aortic aneurysms |
| Q44960480 | Identification of a biologically active component in minimally oxidized low density lipoprotein (MM-LDL) responsible for aortic smooth muscle cell proliferation |
| Q43263111 | Iloprost inhibits superoxide formation and gp91phox expression induced by the thromboxane A2 analogue U46619, 8-isoprostane F2alpha, prostaglandin F2alpha, cytokines and endotoxin in the pig pulmonary artery |
| Q42873285 | Impact of RGS2 deficiency on the therapeutic effect of telmisartan in angiotensin II-induced aortic aneurysm |
| Q35364697 | Impaired glutathione redox system paradoxically suppresses angiotensin II-induced vascular remodeling |
| Q34426146 | Impaired relaxation of cerebral arteries in the absence of elevated salt intake in normotensive congenic rats carrying the Dahl salt-sensitive renin gene |
| Q36421164 | Important aspects of urine sampling for angiotensinogen measurement: time and preservation conditions in healthy individuals |
| Q73288879 | Improved endothelial function with angiotensin-converting enzyme inhibitors |
| Q64069141 | Improvement in Diabetic Retinopathy through Protection against Retinal Apoptosis in Spontaneously Diabetic Torii Rats Mediated by Ethanol Extract of C.K. Schneid |
| Q92823526 | In Vitro and In Vivo Antioxidant Properties of Taraxacum officinale in Nω-Nitro-l-Arginine Methyl Ester (L-NAME)-Induced Hypertensive Rats |
| Q73515085 | In human hypercholesterolemia increased reactivity of vascular smooth muscle cells is due to altered subcellular Ca(2+) distribution |
| Q44589042 | Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment |
| Q33527029 | Increased expression of endothelin ET(B) and angiotensin AT(1) receptors in peripheral resistance arteries of patients with suspected acute coronary syndrome |
| Q80001226 | Increased superoxide anion production is associated with early atherosclerosis and cardiovascular dysfunctions in a rabbit model |
| Q34489884 | Increasing glucose 6-phosphate dehydrogenase activity restores redox balance in vascular endothelial cells exposed to high glucose |
| Q36956379 | Inflammation and endothelial dysfunction during aging: role of NF-kappaB |
| Q35613484 | Influence of obesity and metabolic dysfunction on the endothelial control in the coronary circulation |
| Q36949963 | Inhibition of NADPH Oxidase Mediates Protective Effect of Cardiotonic Pills against Rat Heart Ischemia/Reperfusion Injury |
| Q28569170 | Inhibition of NADPH-cytochrome P450 reductase and glyceryl trinitrate biotransformation by diphenyleneiodonium sulfate |
| Q35013600 | Inhibition of NF-κB-induced inflammatory responses by angiotensin II antagonists in aged rat kidney |
| Q37422104 | Inhibition of biliverdin reductase increases ANG II-dependent superoxide levels in cultured renal tubular epithelial cells |
| Q37406883 | Inhibition of the renin-angiotensin system and target organ protection |
| Q35416745 | Insulin reverses D-glucose-increased nitric oxide and reactive oxygen species generation in human umbilical vein endothelial cells |
| Q57787242 | Interference With Endothelial PPAR (Peroxisome Proliferator-Activated Receptor)-γ Causes Accelerated Cerebral Vascular Dysfunction in Response to Endogenous Renin-Angiotensin System Activation |
| Q34724693 | Intestinal NADPH oxidase 2 activity increases in a neonatal rat model of necrotizing enterocolitis. |
| Q41491665 | Introgression of the Brown Norway renin allele onto the Dahl salt-sensitive genetic background increases Cu/Zn SOD expression in cerebral arteries |
| Q42120155 | Involvement of H2O2 in superoxide-dismutase-induced enhancement of endothelium-dependent relaxation in rabbit mesenteric resistance artery |
| Q41962924 | Involvement of an NAD(P)H oxidase-like enzyme in superoxide anion and hydrogen peroxide generation by rat type II cells |
| Q36091351 | Involvement of the intrarenal renin-angiotensin system in experimental models of glomerulonephritis |
| Q35056901 | Inward remodeling of resistance arteries requires reactive oxygen species-dependent activation of matrix metalloproteinases |
| Q35047383 | Irbesartan inhibits human T-lymphocyte activation through downregulation of activator protein-1. |
| Q32054951 | Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis |
| Q43796478 | Irbesartan, an angiotensin type 1 receptor inhibitor, regulates the vascular oxidative state in patients with coronary artery disease |
| Q41603069 | Is there a rationale for combining angiotensin-converting enzyme inhibitors and calcium antagonists in cardiovascular disease? |
| Q37344438 | Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation |
| Q34357797 | Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and activation of Akt-eNOS signaling |
| Q36029511 | Kallistatin inhibits TGF-β-induced endothelial-mesenchymal transition by differential regulation of microRNA-21 and eNOS expression |
| Q36023483 | Kidney-specific enhancement of ANG II stimulates endogenous intrarenal angiotensinogen in gene-targeted mice. |
| Q44472433 | Lessons learned from experimental myocarditis |
| Q35101890 | Lipid raft redox signaling: molecular mechanisms in health and disease |
| Q35126614 | Lipopolysaccharide (LPS)-mediated angiopoietin-2-dependent autocrine angiogenesis is regulated by NADPH oxidase 2 (Nox2) in human pulmonary microvascular endothelial cells |
| Q95380074 | Lisinopril inhibits endothelin-1 in the early period of hepatic reperfusion injury in a partial hepatectomy model |
| Q37828412 | Local bone marrow Renin-Angiotensin system and atherosclerosis |
| Q42670850 | Localization of NADPH oxidase in sympathetic and sensory ganglion neurons and perivascular nerve fibers |
| Q36821496 | Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II |
| Q36909397 | Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy |
| Q84963903 | Losartan abolishes oxidative stress induced by intermittent hypoxia in humans |
| Q43166520 | Losartan improved respiratory function and coenzyme Q content in brain mitochondria of young spontaneously hypertensive rats |
| Q37250956 | Losartan improves impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type 1 diabetic rats |
| Q42509129 | Loss of Smooth Muscle α-Actin Leads to NF-κB-Dependent Increased Sensitivity to Angiotensin II in Smooth Muscle Cells and Aortic Enlargement. |
| Q35177092 | Loss of angiotensin II receptor expression in dopamine neurons in Parkinson's disease correlates with pathological progression and is accompanied by increases in Nox4- and 8-OH guanosine-related nucleic acid oxidation and caspase-3 activation |
| Q34473866 | Low mercury concentration produces vasoconstriction, decreases nitric oxide bioavailability and increases oxidative stress in rat conductance artery. |
| Q36968881 | Low-dose angiotensin II infusion restores vascular function in cerebral arteries of high salt-fed rats by increasing copper/zinc superoxide dimutase expression |
| Q41922173 | Lung injury and oxidoreductases |
| Q36162737 | Luteolin Ameliorates Hypertensive Vascular Remodeling through Inhibiting the Proliferation and Migration of Vascular Smooth Muscle Cells |
| Q32062986 | Lysophosphatidylcholine increases the secretion of matrix metalloproteinase 2 through the activation of NADH/NADPH oxidase in cultured aortic endothelial cells |
| Q40347239 | Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells. |
| Q46423522 | Macrophages come to mind as keys to cognitive decline |
| Q38965333 | Macrophages in neuroinflammation: role of the renin-angiotensin-system. |
| Q37730653 | Management of cardiorenal metabolic syndrome in diabetes mellitus: a phytotherapeutic perspective |
| Q91801597 | Maternal high-sodium intake affects the offspring' vascular renin-angiotensin system promoting endothelial dysfunction in rats |
| Q34764783 | Matrix metalloproteinase-3 causes dopaminergic neuronal death through Nox1-regenerated oxidative stress |
| Q44037751 | Measuring reactive oxygen species inhibition of endothelin-converting enzyme |
| Q74595353 | Mechanism by which quinapril improves vascular function in coronary artery disease |
| Q40269875 | Mechanisms of potentiation of Angiotensin II-induced contractile response of isolated rat aorta by hydrogen peroxide and tert-butyryl hydroperoxide |
| Q37062099 | Mechanisms of radiation-induced brain toxicity and implications for future clinical trials |
| Q33934937 | Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors |
| Q37118254 | Membrane raft redox signalosomes in endothelial cells |
| Q35031623 | Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease. |
| Q36093354 | Metabolic dysfunction in obstructive sleep apnea: A critical examination of underlying mechanisms |
| Q34442434 | Methylglyoxal scavengers attenuate endothelial dysfunction induced by methylglyoxal and high concentrations of glucose |
| Q36938178 | Microarray gene expression profiling reveals antioxidant-like effects of angiotensin II inhibition in atherosclerosis |
| Q39169210 | Microvascular NADPH oxidase in health and disease. |
| Q34600173 | Mitochondria as signaling organelles in the vascular endothelium |
| Q38268844 | Mitochondria: a pathogenic paradigm in hypertensive renal disease |
| Q43116432 | Mitochondrial dysfunction and mitochondrial-produced reactive oxygen species: new targets for neurogenic hypertension? |
| Q38266758 | Mitochondrial injury and dysfunction in hypertension-induced cardiac damage |
| Q46432453 | Mitochondrial redox plays a critical role in the paradoxical effects of NAPDH oxidase-derived ROS on coronary endothelium. |
| Q44022921 | Mitochondrial superoxide production during oxalate-mediated oxidative stress in renal epithelial cells |
| Q35178446 | Modulating atherosclerosis through inhibition or blockade of angiotensin |
| Q34541203 | Modulation of redox signaling promotes apoptosis in epithelial ovarian cancer cells |
| Q40895409 | Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2(Akita) diabetic mice |
| Q28070313 | Molecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models |
| Q33807091 | Molecular Signals Elicited by GPCR Agonists in Hypertension, Cardiovascular Remodeling: Are MMPs and ADAMs Elusive Therapeutic Targets? |
| Q44574646 | Multiple actions of angiotensin II in hypertension: benefits of AT1 receptor blockade |
| Q74106093 | Multiple cytokines regulate the expression of extracellular superoxide dismutase in human vascular smooth muscle cells |
| Q28300003 | Myosin regulation in the migration of tumor cells and leukocytes within a three-dimensional collagen matrix |
| Q44417520 | NAD(P)H oxidase activation by angiotensin II is dependent on p42/44 ERK-MAPK pathway activation in rat's vascular smooth muscle cells |
| Q33593365 | NAD(P)H oxidases in coronary artery disease. |
| Q63365800 | NADH/NADPH Oxidase and Vascular Function |
| Q35115451 | NADPH Oxidase in Endothelial Cells: Impact on Atherosclerosis |
| Q42588680 | NADPH oxidase 4 mediates TGF-β-induced smooth muscle α-actin via p38MAPK and serum response factor |
| Q73303463 | NADPH oxidase activity is required for endothelial cell proliferation and migration |
| Q44939750 | NADPH oxidase contributes to angiotensin II signaling in the nucleus tractus solitarius. |
| Q37138926 | NADPH oxidase contributes to coronary endothelial dysfunction in the failing heart |
| Q28571522 | NADPH oxidase mediates radiation-induced oxidative stress in rat brain microvascular endothelial cells |
| Q34766266 | NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system? |
| Q36001842 | NADPH oxidase-derived H(2)O(2) contributes to angiotensin II-induced aldosterone synthesis in human and rat adrenal cortical cells |
| Q34054215 | NADPH oxidase: a universal oxygen sensor? |
| Q37342232 | NADPH oxidases and angiotensin II receptor signaling |
| Q90576094 | NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets |
| Q27001094 | NADPH oxidases in heart failure: poachers or gamekeepers? |
| Q33632089 | NADPH oxidases in vascular pathology |
| Q36302873 | NADPH oxidases: an overview from structure to innate immunity-associated pathologies |
| Q39988593 | NADPH oxidases: molecular understanding finally reaching the clinical level? |
| Q31148000 | NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide. |
| Q28295706 | NF-E2-related factor 2 promotes atherosclerosis by effects on plasma lipoproteins and cholesterol transport that overshadow antioxidant protection |
| Q42701348 | NOX and inflammation in the vascular adventitia |
| Q40133141 | NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. |
| Q50126148 | Natriuretic peptide receptor-C activation attenuates angiotensin II-induced enhanced oxidative stress and hyperproliferation of aortic vascular smooth muscle cells. |
| Q30940745 | Negative feedback regulation of reactive oxygen species on AT1 receptor gene expression |
| Q37965160 | Neural degeneration in the retina of the streptozotocin-induced type 1 diabetes model |
| Q35116071 | Neuronal and non-neuronal modulation of sympathetic neurovascular transmission |
| Q37718340 | New antiarrhythmic drugs for treatment of atrial fibrillation. |
| Q40991742 | New insights into mechanisms underlying nitrate tolerance |
| Q90989969 | Newly manufactured Marukome MK-34-1 miso with angiotensin-converting enzyme inhibitory activity and its antihypertensive effects in genetic hypertensive rat models |
| Q60077919 | News and Views |
| Q39024659 | Nicotinamide adenine dinucleotide phosphate oxidase is differentially regulated in normal myometrium versus leiomyoma |
| Q35583191 | Nitrate tolerance and the links with endothelial dysfunction and oxidative stress |
| Q38605600 | Nitric oxide and cardiovascular risk factors. |
| Q37034771 | Nitric oxide generation by the organic nitrate NDBP attenuates oxidative stress and angiotensin II-mediated hypertension |
| Q73807241 | Nitric oxide in heart failure |
| Q30486865 | Nitric oxide synthase-dependent responses of the basilar artery during acute infusion of nicotine |
| Q44612476 | Nitrosonifedipine ameliorates angiotensin II-induced vascular remodeling via antioxidative effects |
| Q35551180 | Noncholesterol-Lowering Effects of Statins |
| Q35004286 | Noninvasive in vivo imaging of diabetes-induced renal oxidative stress and response to therapy using hyperpolarized 13C dehydroascorbate magnetic resonance. |
| Q37346056 | Norepinephrine increases NADPH oxidase-derived superoxide in human peripheral blood mononuclear cells via α-adrenergic receptors |
| Q90744103 | Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases |
| Q34069745 | Novel homologs of gp91phox. |
| Q28483560 | Novel role of NOX in supporting aerobic glycolysis in cancer cells with mitochondrial dysfunction and as a potential target for cancer therapy |
| Q36168729 | Novel sandwich ELISA for human angiotensinogen |
| Q37392163 | Nox proteins in signal transduction |
| Q37139048 | Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells |
| Q35896207 | Nox4 oxidase overexpression specifically decreases endogenous Nox4 mRNA and inhibits angiotensin II-induced adventitial myofibroblast migration |
| Q36411174 | O2 sensing is preserved in mice lacking the gp91 phox subunit of NADPH oxidase |
| Q46738694 | Olmesartan protects endothelial cells against oxidative stress-mediated cellular injury. |
| Q37679126 | Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells |
| Q37430733 | Oxalate-induced activation of PKC-alpha and -delta regulates NADPH oxidase-mediated oxidative injury in renal tubular epithelial cells |
| Q33743649 | Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load |
| Q34107235 | Oxidant stress in the vasculature |
| Q41260199 | Oxidants as stimulators of signal transduction |
| Q28393242 | Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling |
| Q30080036 | Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension |
| Q42776854 | Oxidative Stress and Vascular Damage in Hypertension: Role of Angiotensin II. |
| Q35760065 | Oxidative inhibition of the vascular Na+-K+ pump via NADPH oxidase-dependent β1-subunit glutathionylation: implications for angiotensin II-induced vascular dysfunction |
| Q37867946 | Oxidative stress and endothelial dysfunction in hypertension |
| Q82623891 | Oxidative stress and enhanced sympathetic vasoconstriction in contracting muscles of nitrate-tolerant rats and humans |
| Q34038044 | Oxidative stress and metabolic pathologies: from an adipocentric point of view. |
| Q38228080 | Oxidative stress and organ damages |
| Q36015440 | Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases |
| Q37738027 | Oxidative stress and vascular function: implications for pharmacologic treatments |
| Q33818137 | Oxidative stress and vascular smooth muscle cell growth: a mechanistic linkage by cyclophilin A |
| Q46464910 | Oxidative stress augments chemoreflex sensitivity in rats exposed to chronic intermittent hypoxia |
| Q46842368 | Oxidative stress contributes to renovascular hypertension. |
| Q92184944 | Oxidative stress contributes to vascular calcification in patients with chronic kidney disease |
| Q42589408 | Oxidative stress improves coronary endothelial function through activation of the pro-survival kinase AMPK. |
| Q35087692 | Oxidative stress in diabetic nephropathy: basic and clinical information |
| Q37820092 | Oxidative stress in early diabetic nephropathy: fueling the fire |
| Q37900100 | Oxidative stress in heart failure: what are we missing? |
| Q48415409 | Oxidative stress in the brain and arterial hypertension. |
| Q46116463 | Oxidative stress in the sympathetic premotor neurons contributes to sympathetic activation in renovascular hypertension. |
| Q34456692 | Oxidative stress markers in Korean subjects with insulin resistance syndrome |
| Q44258753 | Oxidative stress, NO* and smooth muscle cell extracellular superoxide dismutase expression |
| Q43086910 | Oxidative stress, the capo of endothelial dysfunction in chronic renovascular hypertension. |
| Q38213038 | Oxidative stress: A cause and therapeutic target of diabetic complications |
| Q43081749 | Oxidative stress: Predictive marker for coronary artery disease |
| Q41750986 | Oxygen radicals and signaling |
| Q37016695 | Oxytocin attenuates NADPH-dependent superoxide activity and IL-6 secretion in macrophages and vascular cells |
| Q35403487 | PPARγ ligands regulate NADPH oxidase, eNOS, and barrier function in the lung following chronic alcohol ingestion |
| Q35639923 | PPARδ coordinates angiotensin II-induced senescence in vascular smooth muscle cells through PTEN-mediated inhibition of superoxide generation |
| Q38165049 | Pathogenesis of chronic cardiorenal syndrome: is there a role for oxidative stress? |
| Q57296797 | Pathophysiological Alterations of Redox Signaling and Endocannabinoid System in Granulocytes and Plasma of Psoriatic Patients |
| Q41870373 | Perindopril may improve the hippocampal reduced glutathione content in rats |
| Q34229717 | Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor, omapatrilat in healthy subjects |
| Q54110304 | Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKCα/Gal-3 pathway reduces left ventricular fibrosis following myocardial infarction. |
| Q33902193 | Pharmacological management of atrial fibrillation: one, none, one hundred thousand. |
| Q37978478 | Pharmacological targets in the renal peritubular microenvironment: implications for therapy for sepsis-induced acute kidney injury |
| Q23910430 | Phosphatidylinositol 3-kinase/Akt positively regulates fas (CD95)-mediated apoptosis in epidermal Cl41 cells |
| Q46150245 | Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs). |
| Q47839310 | Plasma detection of NO by a catheter |
| Q43919813 | Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure |
| Q44574645 | Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients |
| Q55114983 | Possible Role of NADPH Oxidase 4 in Angiotensin II-Induced Muscle Wasting in Mice. |
| Q77709146 | Potential mechanisms for the effect of angiotensin-converting enzyme inhibitors on endothelial dysfunction: the role of nitric oxide |
| Q35118290 | Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia |
| Q39660661 | Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats |
| Q41949181 | Prednisolone augments superoxide formation in porcine pulmonary artery endothelial cells through differential effects on the expression of nitric oxide synthase and NADPH oxidase |
| Q34048574 | President's address. Common mechanisms of multiple diseases: why vegetables and exercise are good for you. |
| Q37002708 | Prevention of TGFβ induction attenuates angII-stimulated vascular biglycan and atherosclerosis in Ldlr-/- mice |
| Q36893345 | Prevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiotensin II-induced hypertension |
| Q82381723 | Preventive effects of syngeneic bone marrow transplantation on diabetic nephropathy in mice |
| Q33942155 | Prolonged fasting does not increase oxidative damage or inflammation in postweaned northern elephant seal pups |
| Q37169153 | Prostaglandin F2alpha elevates blood pressure and promotes atherosclerosis. |
| Q37381258 | Protection from reoxygenation injury by inhibition of rac1. |
| Q33729668 | Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of the gp91phox gene |
| Q94560950 | Protective Effects of Short-Chain Fatty Acids on Endothelial Dysfunction Induced by Angiotensin II |
| Q43182745 | Protective effect of sitagliptin and rosuvastatin combination on vascular endothelial dysfunction in type-2 diabetes. |
| Q42241241 | Protective effects of aspirin from cardiac hypertrophy and oxidative stress in cardiomyopathic hamsters |
| Q42526837 | Protective properties of artichoke (Cynara scolymus) against oxidative stress induced in cultured endothelial cells and monocytes |
| Q35710671 | PsANT, the adenine nucleotide translocase of Puccinia striiformis, promotes cell death and fungal growth |
| Q33769358 | Pulmonary endothelial cell NOX |
| Q24298708 | Pyk2- and Src-dependent tyrosine phosphorylation of PDK1 regulates focal adhesions |
| Q38522640 | Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway |
| Q43891469 | Quinacrine increases endothelial nitric oxide release: role of superoxide anion |
| Q34511006 | Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders |
| Q28396460 | ROS, Notch, and Wnt signaling pathways: crosstalk between three major regulators of cardiovascular biology |
| Q39396774 | ROS-modulated therapeutic approaches in cancer treatment. |
| Q36955833 | Radical-free biology of oxidative stress |
| Q28580234 | Ramipril mitigates radiation-induced impairment of neurogenesis in the rat dentate gyrus |
| Q90734035 | Rapamycin Treatment Attenuates Angiotensin II -induced Abdominal Aortic Aneurysm Formation via VSMC Phenotypic Modulation and Down-regulation of ERK1/2 Activity |
| Q30491698 | Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data |
| Q37376997 | Reactive oxygen and nitrogen species in pulmonary hypertension |
| Q50863678 | Reactive oxygen species and antioxidant defense in human gastrointestinal diseases. |
| Q36449410 | Reactive oxygen species and p47phox activation are essential for the Mycobacterium tuberculosis-induced pro-inflammatory response in murine microglia |
| Q34028162 | Reactive oxygen species and the control of vasomotor tone |
| Q33927958 | Reactive oxygen species and vascular cell apoptosis in response to angiotensin II and pro-atherosclerotic factors |
| Q34019811 | Reactive oxygen species as mediators of angiotensin II signaling |
| Q37828680 | Reactive oxygen species as mediators of signal transduction in cardiovascular disease |
| Q46522556 | Reactive oxygen species derived from NADPH oxidase 1 and mitochondria mediate angiotensin II-induced smooth muscle cell senescence |
| Q35963391 | Reactive oxygen species derived from Nox4 mediate BMP2 gene transcription and osteoblast differentiation. |
| Q43935541 | Reactive oxygen species differentially affect T cell receptor-signaling pathways. |
| Q37431048 | Reactive oxygen species in cancer |
| Q36674343 | Reactive oxygen species in the neuropathogenesis of hypertension |
| Q35874976 | Reactive oxygen species in vascular biology: implications in hypertension |
| Q37713975 | Reactive oxygen species mediate angiotensin II-induced transcytosis of low-density lipoprotein across endothelial cells. |
| Q33601934 | Reactive oxygen species mediate mitogenic growth factor signaling pathways in human leiomyoma smooth muscle cells |
| Q37361893 | Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability |
| Q36450264 | Reactive oxygen species signaling in vascular smooth muscle cells |
| Q36392238 | Reactive oxygen species: toxic molecules or spark of life? |
| Q36842628 | Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes |
| Q57117618 | Redox Balance, Antioxidant Defense, and Oxidative Damage in the Hypothalamus and Cerebral Cortex of Rats with High Fat Diet-Induced Insulin Resistance |
| Q46256827 | Redox Control of Vascular Function |
| Q38130100 | Redox balance in the aged endothelium. |
| Q37510851 | Redox control of the cell cycle in health and disease |
| Q33690103 | Redox control of vascular smooth muscle migration |
| Q63365790 | Redox control of vascular smooth muscle proliferation |
| Q35748228 | Redox regulation of angiotensin II signaling in the heart. |
| Q36476273 | Redox regulation of epidermal growth factor receptor signaling through cysteine oxidation |
| Q35296178 | Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction |
| Q37446110 | Redox signaling in cardiovascular health and disease. |
| Q46249417 | Redox system and phospholipid metabolism in the kidney of hypertensive rats after FAAH inhibitor URB597 administration. |
| Q44413513 | Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation |
| Q33957112 | Redox-dependent signal transduction |
| Q41880895 | Reduced angiotensin II levels cause generalized vascular dysfunction via oxidant stress in hamster cheek pouch arterioles. |
| Q84672976 | Reduction of circulating superoxide dismutase activity in type 2 diabetic patients with microalbuminuria and its modulation by telmisartan therapy |
| Q28361065 | Reduction of oxidative stress and AT1 receptor expression by the selective oestrogen receptor modulator idoxifene |
| Q35925959 | Regulation of NAD(P)H oxidases by AMPK in cardiovascular systems |
| Q37100479 | Regulation of T-cell function by endogenously produced angiotensin II. |
| Q30406156 | Regulation of cellular communication by signaling microdomains in the blood vessel wall |
| Q37430939 | Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure |
| Q35153563 | Regulation of oxidative stress-induced calcium release by phosphatidylinositol 3-kinase and Bruton's tyrosine kinase in B cells |
| Q43577316 | Regulation of prostacyclin synthesis by angiotensin II and TNF-alpha in vascular smooth muscle |
| Q42809514 | Regulation of reactive-oxygen-species generation in fibroblasts by Rac1. |
| Q37058920 | Regulation of the renin-angiotensin system in coronary atherosclerosis: a review of the literature |
| Q37632261 | Reinventing the ACE inhibitors: some old and new implications of ACE inhibition |
| Q43648736 | Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathy |
| Q78107902 | Relationship of the C242T p22phox gene polymorphism to angiographic coronary artery disease and endothelial function |
| Q28298575 | Relationship of the p22phox (CYBA) gene polymorphism C242T with risk of coronary artery disease: a meta-analysis |
| Q28082365 | Renal autoregulation in health and disease |
| Q34501842 | Renal denervation modulates angiotensin receptor expression in the renal cortex of rabbits with chronic heart failure. |
| Q37900203 | Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment |
| Q35203828 | Renin angiotensin system and gender differences in dopaminergic degeneration. |
| Q36458652 | Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice |
| Q42098043 | Renin-Angiotensin system hyperactivation can induce inflammation and retinal neural dysfunction |
| Q36784673 | Renin-angiotensin system and cardiovascular risk |
| Q39404819 | Renin-angiotensin system gene expression and neurodegenerative diseases |
| Q44260226 | Resistance to hyperoxia with heme oxygenase-1 disruption: role of iron |
| Q26821967 | Review article: pancreatic renin-angiotensin systems in health and disease |
| Q39700439 | Rho family GTPases are required for activation of Jak/STAT signaling by G protein-coupled receptors |
| Q35176118 | Rho-kinase/nuclear factor-κβ/angiotensinogen axis in angiotensin II-induced renal injury |
| Q48542818 | Robert Wayne Alexander, M.D., PH.D. |
| Q33965815 | Role for mitochondrial oxidants as regulators of cellular metabolism |
| Q28196501 | Role of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors, angiotensin-converting enzyme inhibitors, cyclooxygenase-2 inhibitors, and aspirin in anti-inflammatory and immunomodulatory treatment of cardiovascular diseases |
| Q38626384 | Role of Matrix Metalloproteinases in the Pathogenesis of Traumatic Brain Injury |
| Q36495144 | Role of NADPH oxidase and iNOS in vasoconstrictor responses of vessels from hypertensive and normotensive rats. |
| Q43263113 | Role of PKC in the attenuation of the cGMP-mediated relaxation of skinned resistance artery smooth muscle seen in glyceryl-trinitrate-tolerant rabbit |
| Q39238324 | Role of Tissue Renin-angiotensin System and the Chymase/angiotensin-(1-12) axis in the Pathogenesis of Diabetic Retinopathy |
| Q37808491 | Role of angiotensin II in the development of nephropathy and podocytopathy of diabetes |
| Q77102720 | Role of angiotensin-converting enzyme inhibition in reversal of endothelial dysfunction in coronary artery disease |
| Q35172806 | Role of ferulic acid in the amelioration of ionizing radiation induced inflammation: a murine model |
| Q39675810 | Role of mitochondrial-derived oxidants in renal tubular cell cold-storage injury |
| Q50497066 | Role of nitric oxide on the vasorelaxant effect of atrial natriuretic peptide on rabbit aorta basal tone. |
| Q37045445 | Role of oxidative stress and nitric oxide in atherothrombosis |
| Q42265679 | Role of oxidative stress and nitric oxide in regulation of spontaneous tone in aorta of DOCA-salt hypertensive rats |
| Q40378762 | Role of oxidative stress in angiotensin-II mediated contraction of human conduit arteries in patients with cardiovascular disease. |
| Q35581462 | Role of oxidative stress in disease progression in Stage B, a pre-cursor of heart failure |
| Q36525653 | Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. |
| Q36229028 | Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction |
| Q30424339 | Role of the immune system in hypertension: modulation by dietary antioxidants |
| Q34306932 | Role of the renin-angiotensin system in the pathogenesis of intimal hyperplasia: therapeutic potential for prevention of vein graft failure? |
| Q36890881 | Role of uncoupled endothelial nitric oxide synthase in abdominal aortic aneurysm formation: treatment with folic acid |
| Q37167578 | Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress |
| Q34046462 | Role of vascular smooth muscle PPARγ in regulating AT1 receptor signaling and angiotensin II-dependent hypertension |
| Q28594591 | Roles of peroxiredoxin II in the regulation of proinflammatory responses to LPS and protection against endotoxin-induced lethal shock |
| Q37688383 | Rosiglitazone preserves pulmonary vascular function in lambs with increased pulmonary blood flow |
| Q36929431 | Rosuvastatin prevents angiotensin II-induced vascular changes by inhibition of NAD(P)H oxidase and COX-1. |
| Q41994308 | Rutin as a Mediator of Lipid Metabolism and Cellular Signaling Pathways Interactions in Fibroblasts Altered by UVA and UVB Radiation. |
| Q35582293 | SOXF: redox mediators of vascular smooth muscle cell growth |
| Q38693277 | Salt, Angiotensin II, Superoxide, and Endothelial Function |
| Q37778985 | Salt, aldosterone, and insulin resistance: impact on the cardiovascular system |
| Q49921149 | Sex Differences in Abdominal Aortic Aneurysms. |
| Q90492111 | Sildenafil Protects Endothelial Cells From Radiation-Induced Oxidative Stress |
| Q42324363 | Simvastatin and losartan differentially and synergistically inhibit atherosclerosis in apolipoprotein e(-/-) mice |
| Q54917997 | Skeletal muscle bioenergetics in aging and heart failure. |
| Q35939806 | Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cells |
| Q38072702 | Smoking in diabetic nephropathy: sparks in the fuel tank? |
| Q34280178 | Smooth muscle cell apoptosis in arteriosclerosis |
| Q48919718 | Sodium and Potassium Relating to Parkinson's Disease and Traumatic Brain Injury. |
| Q31149563 | Sodium ferulate inhibits neointimal hyperplasia in rat balloon injury model |
| Q92022823 | Soluble angiotensin converting enzyme 2 levels in chronic heart failure is associated with decreased exercise capacity and increased oxidative stress-mediated endothelial dysfunction |
| Q58075704 | Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation |
| Q35936804 | Statin therapy for cardiac hypertrophy and heart failure |
| Q35828423 | Statins and myocardial hypertrophy |
| Q36110624 | Statins and the myocardium |
| Q41972833 | Stimulation of arterial smooth muscle L-type calcium channels by hydrogen peroxide requires protein kinase C. |
| Q35178628 | Stressing the system. |
| Q30519970 | Sub-Nanomolar Sensitivity of Nitric Oxide Mediated Regulation of cGMP and Vasomotor Reactivity in Vascular Smooth Muscle |
| Q58125911 | Superoxide Dismutase Activity in Small Mesenteric Arteries Is Downregulated by Angiotensin II but Not by Hypertension |
| Q35045534 | Superoxide dismutase mimetic M40403 improves endothelial function in apolipoprotein(E)-deficient mice |
| Q34455923 | Superoxide generation of phagocytes and nonphagocytic cells |
| Q53647150 | Superoxide production and oxygen consumption in endothelium-intact and -denuded artery stimulated by angiotensin II. |
| Q77379588 | Superoxide scavenging effect of Ginkgo biloba extract on serotonin-induced mitogenesis |
| Q46322063 | Suppression of atrial natriuretic peptide/natriuretic peptide receptor-A-mediated signaling upregulates angiotensin-II-induced collagen synthesis in adult cardiac fibroblasts |
| Q53592062 | Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice. |
| Q41573480 | Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms |
| Q36193746 | Sympathetic regulation of vascular function in health and disease. |
| Q37352389 | Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension |
| Q36702981 | Tanshinone IIA and Cryptotanshinone Prevent Mitochondrial Dysfunction in Hypoxia-Induced H9c2 Cells: Association to Mitochondrial ROS, Intracellular Nitric Oxide, and Calcium Levels |
| Q26863500 | Targeting NADPH oxidases in vascular pharmacology |
| Q37376499 | Targeting cardiac sympatho-vagal imbalance using gene transfer of nitric oxide synthase |
| Q38009736 | Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors |
| Q51034962 | Telmisartan ameliorates neurotrophic support and oxidative stress in the retina of streptozotocin-induced diabetic rats. |
| Q35036184 | Telmisartan, ramipril and their combination improve endothelial function in different tissues in a murine model of cholesterol-induced atherosclerosis |
| Q46907016 | Temporal effects of low-dose ACE inhibition on endothelial function in Type 1 diabetic patients |
| Q43264469 | Tetrahydrobiopterin impairs the action of endothelial nitric oxide via superoxide derived from platelets |
| Q58696656 | The Effect of Long-Term Administration of Fatty Acid Amide Hydrolase Inhibitor URB597 on Oxidative Metabolism in the Heart of Rats with Primary and Secondary Hypertension |
| Q89719234 | The Effect of N-Acetylcysteine on Respiratory Enzymes, ADP/ATP Ratio, Glutathione Metabolism, and Nitrosative Stress in the Salivary Gland Mitochondria of Insulin Resistant Rats |
| Q58710605 | The Effect of Sea Buckthorn ( L.) Seed Oil on UV-Induced Changes in Lipid Metabolism of Human Skin Cells |
| Q92241256 | The Impact of High-Fat Diet on Mitochondrial Function, Free Radical Production, and Nitrosative Stress in the Salivary Glands of Wistar Rats |
| Q42945503 | The Jeremiah Metzger Lecture. Pathogenesis of atherosclerosis: redox as a unifying mechanism. |
| Q39123362 | The NRF2 knockout rat: a new animal model to study endothelial dysfunction, oxidant stress, and microvascular rarefaction |
| Q38241109 | The acute cardiorenal syndrome: burden and mechanisms of disease |
| Q37309054 | The antihypertensive effect of arginine |
| Q37291570 | The antihypertensive effect of cysteine |
| Q34340391 | The cardiorenal syndrome: making the connection |
| Q35548796 | The clinical implications of endothelial dysfunction |
| Q90299244 | The contribution of chymase-dependent formation of ANG II to cardiac dysfunction in metabolic syndrome of young rats: roles of fructose and EETs |
| Q46435677 | The effects of the overexpression of recombinant uncoupling protein 2 on proliferation, migration and plasminogen activator inhibitor 1 expression in human vascular smooth muscle cells |
| Q73357066 | The influence of endogenously generated reactive oxygen species on the inotropic and chronotropic effects of adrenoceptor and ET-receptor stimulation |
| Q73193166 | The insertion/deletion polymorphism of the angiotensin-converting enzyme gene determines coronary vascular tone and nitric oxide activity |
| Q28578712 | The involvement of aldosterone in cyclic stretch-mediated activation of NADPH oxidase in vascular smooth muscle cells |
| Q36102167 | The metabolic syndrome, oxidative stress, environment, and cardiovascular disease: the great exploration |
| Q38074245 | The mosaic theory revisited: common molecular mechanisms coordinating diverse organ and cellular events in hypertension |
| Q34060768 | The multiple actions of angiotensin II in atherosclerosis |
| Q28144464 | The p22 phox A640G gene polymorphism but not the C242T gene variation is associated with coronary heart disease in younger individuals |
| Q64990581 | The pathophysiological basis of vascular disease. |
| Q41540463 | The physiology and pathophysiology of the nitric oxide/superoxide system |
| Q37361567 | The potential role of MLC phosphatase and MAPK signalling in the pathogenesis of vascular dysfunction in heart failure |
| Q33632757 | The quest for selective nox inhibitors and therapeutics: challenges, triumphs and pitfalls |
| Q28609860 | The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study |
| Q42451386 | The receptors and role of angiotensin II in knee joint blood flow regulation and role of nitric oxide in modulation of their function |
| Q37475546 | The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress |
| Q36442587 | The renin-angiotensin system and atherosclerosis |
| Q36424627 | The role of Nox-mediated oxidation in the regulation of cytoskeletal dynamics |
| Q42043961 | The role of adrenomedullin in the renal NADPH oxidase and (pro)renin in diabetic mice |
| Q38253635 | The role of local renin-angiotensin system in arterial chemoreceptors in sleep-breathing disorders |
| Q61843052 | The role of nitric oxide in the regulation of myocardial relaxation and diastolic function |
| Q62647447 | The role of oxidant stress in angiotensin II-mediated contraction of human resistance arteries in the state of health and the presence of cardiovascular disease |
| Q39936328 | The role of urate and xanthine oxidase in vascular oxidative stress: future directions |
| Q46391414 | The role played by oxidative stress in evoking the exercise pressor reflex in health and simulated peripheral artery disease. |
| Q37178255 | The sweeter side of ACE2: physiological evidence for a role in diabetes |
| Q35090364 | The therapeutic effect of natriuretic peptides in heart failure; differential regulation of endothelial and inducible nitric oxide synthases |
| Q30824712 | The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases |
| Q42521764 | The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression. |
| Q35026157 | Therapeutic inhibition of tumour necrosis factor alpha in patients with heart failure: cooling an inflamed heart. |
| Q46224925 | Thiol antioxidants regulate angiotensin II AT1 and arginine vasopressin V1 receptor functions differently in vascular smooth muscle cells |
| Q40529148 | Thromboxane receptor activates the AMP-activated protein kinase in vascular smooth muscle cells via hydrogen peroxide. |
| Q39711485 | Thyroid hormone induces artery smooth muscle cell proliferation: discovery of a new TRalpha1-Nox1 pathway |
| Q35809634 | Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction |
| Q35740783 | Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation |
| Q42519570 | Tolerance to nitrates and simultaneous upregulation of platelet activity prevented by enhancing antioxidant state |
| Q37709969 | Total flavonoids from Plumula Nelumbinis suppress angiotensin II-induced fractalkine production by inhibiting the ROS/NF-κB pathway in human umbilical vein endothelial cells |
| Q46428405 | Trace analysis of oxidized, nitrated, and chlorinated aromatic amino acids by capillary electrophoresis with electroosmotic flow modification allowing large-volume sample stacking |
| Q37615958 | Translating the oxidative stress hypothesis into the clinic: NOX versus NOS. |
| Q44599816 | Translocation of Glomerular p47phox and p67phox by Protein Kinase C-β Activation Is Required for Oxidative Stress in Diabetic Nephropathy |
| Q35083719 | Transplasma membrane electron transport: enzymes involved and biological function. |
| Q28583958 | Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle |
| Q73222605 | Tyrosine and calcium/calmodulin kinases are common signaling components in the generation of reactive oxygen species in human lymphocytes |
| Q24291589 | Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox |
| Q34022338 | Tyrosine nitration of PA700 activates the 26S proteasome to induce endothelial dysfunction in mice with angiotensin II-induced hypertension |
| Q24650649 | Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction |
| Q88181434 | Understanding Angiotensin II Type 1 Receptor Signaling in Vascular Pathophysiology |
| Q28576215 | Upregulation of Nox4 in the aging vasculature and its association with smooth muscle cell polyploidy |
| Q40765724 | Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo |
| Q42804909 | Uric acid induces oxidative stress via an activation of the renin-angiotensin system in 3T3-L1 adipocytes |
| Q35245800 | Urinary Angiotensinogen as a Novel Biomarker of Intrarenal Renin-Angiotensin System in Chronic Kidney Disease |
| Q42861889 | Urinary angiotensinogen as a biomarker of nephropathy in childhood |
| Q37135790 | Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients |
| Q36951760 | Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases |
| Q33940516 | Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa Heart Study). |
| Q34167806 | Valsartan improves endothelial dysfunction in hypertension: a randomized, double-blind study. |
| Q50211596 | Vascular Smooth Muscle Contraction in Hypertension. |
| Q26774561 | Vascular endothelial dysfunction and pharmacological treatment |
| Q49671689 | Vascular endothelium dysfunction: a conservative target in metabolic disorders. |
| Q35689010 | Vascular injury in systemic sclerosis: angiotensin-converting enzyme insertion/deletion polymorphism |
| Q73978566 | Vascular oxidant stress early after balloon injury: evidence for increased NAD(P)H oxidoreductase activity |
| Q33957964 | Vascular oxidant stress: molecular mechanisms and pathophysiological implications |
| Q35037357 | Vascular smooth muscle Jak2 mediates angiotensin II-induced hypertension via increased levels of reactive oxygen species |
| Q35027751 | Vasoactive substances: nitric oxide and endothelial dysfunction in atherosclerosis |
| Q33701956 | Vasodilator responses to acetylcholine are not mediated by the activation of soluble guanylate cyclase or TRPV4 channels in the rat. |
| Q37102203 | Water-Soluble Components of Sesame Oil Reduce Inflammation and Atherosclerosis |
| Q44940405 | Xanthine oxidase inhibition by 1,3-dipropyl-8-sulfophenylxanthine (DPSPX), an antagonist of adenosine receptors. |
| Q36116868 | Young Scholars Award Lecture: Intratubular angiotensinogen in hypertension and kidney diseases |
| Q74043506 | [Current topics in vascular biology: an update for the 21st century] |
| Q35696706 | p47(phox) is required for afferent arteriolar contractile responses to angiotensin II and perfusion pressure in mice |
| Q28364478 | p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice |
| Q36564448 | rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation |
| Q47120802 | Δ9-Tetrahydrocannabinol Prevents Cardiovascular Dysfunction in STZ-Diabetic Wistar-Kyoto Rats. |
| Q46628069 | α-lipoic acid reduces hypertension and increases baroreflex sensitivity in renovascular hypertensive rats |
| Q42482105 | α1AMP-activated protein kinase preserves endothelial function during chronic angiotensin II treatment by limiting Nox2 upregulation |
Search more.